好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2011 Annual Meeting | Treatment of Movement Disorders

Thursday 04/14/11
01:00 PM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Integrated Neuroscience
Movement Disorders
No CME available
Event Timeline
01:00 PM - 05:00 PM Abstract 001 - Baseline Fitness and Attitude Are Associated with Improved Motor UDPRS in PD Patients in a Randomized Exercise Study
01:00 PM - 05:00 PM Abstract 001 - Strength Training Outcomes for Airway Protection in Parkinson[apos]s Disease
01:00 PM - 05:00 PM Abstract 002 - Assessing the Occurrence of Serotonin Toxicity in Parkinson[apos]s Disease Patients Receiving Rasagiline and Antidepressants
01:00 PM - 05:00 PM Abstract 002 - Long-Term Outcome of Globus Pallidus Stimulation for Dystonia
01:00 PM - 05:00 PM Abstract 003 - Does Amantadine Treatment Protect Against the Development of Pathological Shopping or Gambling in Parkinson[apos]s Disease?
01:00 PM - 05:00 PM Abstract 003 - Ten-Year Follow-Up of Bilateral Subthalamic Stimulation in Advanced Parkinson[apos]s Disease
01:00 PM - 05:00 PM Abstract 004 - Open Labeled Clinical Trial of Rifampicin in Multiple System Atrophy
01:00 PM - 05:00 PM Abstract 004 - Spinal Cord Stimulation Improves Gait and Posture in Advanced Parkinson[apos]s Disease and Progressive Supranuclear Palsy
01:00 PM - 05:00 PM Abstract 005 - Dopamine Agonist Withdrawal Syndrome (DAWS) in a Movement Disorders Clinic
01:00 PM - 05:00 PM Abstract 006 - Levetiracetam in Tourette Syndrome: A Randomized Double Blind, Placebo Controlled Study
01:00 PM - 05:00 PM Abstract 006 - Memantine in Huntington[apos]s Disease: A Randomized, Double Blind, Placebo-Controlled Pilot Study
01:00 PM - 05:00 PM Abstract 007 - Levodopa Is Necessary To Improve Gait and Balance in Parkinson[apos]s Patients after Deep Brain Stimulator Implantation
01:00 PM - 05:00 PM Abstract 008 - Efficacy and Safety of Repeated IncobotulinumtoxinA Injections in Subjects with Cervical Dystonia Previously Treated with Botulinum Toxin
01:00 PM - 05:00 PM Abstract 009 - Safety and Preliminary Efficacy Evaluation of SAM-e and Escitalopram in the Treatment of Depression Associated with PD
01:00 PM - 05:00 PM Abstract 010 - Mesenchymal Stem Cells as a Delivery Vehicle for Intercellular Delivery of RNAi To Treat Huntington[apos]s Disease
01:00 PM - 05:00 PM Abstract 011 - GPi and STN Deep Brain Stimulation Can Suppress and Induce Dyskinesia in Parkinson[apos]s Disease
01:00 PM - 05:00 PM Abstract 012 - Comparison of the Patterns of Motor Response to Levodopa and Subthalamic Nucleus Deep Brain Stimulation
01:00 PM - 05:00 PM Abstract 013 - Six Months of Exercise Improves Cognitive Function in Parkinson[apos]s Disease Patients
Faculty Disclosures
J. E. Ahlskog, MD, PhD Dr. Ahlskog has received publishing royalties from a publication relating to health care.
Michael S. Okun, MD, FAAN Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Anthony E. Lang, MD, FAAN Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
No disclosure on file
Elena Moro, MD, FAAN Dr. Moro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic, Abbott, Kyowa. Dr. Moro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Moro has received research support from Abbott. The institution of Dr. Moro has received research support from IPSEN.
Janis M. Miyasaki, MD, MEd, FAAN Dr. Miyasaki has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Miyasaki has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oxford University Press. The institution of Dr. Miyasaki has received research support from PCORI. The institution of Dr. Miyasaki has received research support from Brain Canada. The institution of Dr. Miyasaki has received research support from Canadian Consortium on Neurodegeneration in Aging. The institution of Dr. Miyasaki has received research support from University Hospital Foundation. The institution of Dr. Miyasaki has received research support from Social Science and Health Research Council.
Kiyobumi Ota No disclosure on file
Robert Goodman No disclosure on file
Seth L. Pullman, MD, FAAN No disclosure on file
Binit Shah, MD, FAAN Dr. Shah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Expert Institute.
Tzvetelina D. Dimitrova, MD No disclosure on file
Hubert H. Fernandez, MD, FAAN Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Ramon L. Rodriguez Cruz, MD, FAAN The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus . The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyoway Kirin. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Rodriguez Cruz has received research support from Cerevance. The institution of Dr. Rodriguez Cruz has received research support from Neuraly. The institution of Dr. Rodriguez Cruz has received research support from Amneal. The institution of Dr. Rodriguez Cruz has received research support from Teva. The institution of Dr. Rodriguez Cruz has received research support from Neurocrine. Dr. Rodriguez Cruz has received publishing royalties from a publication relating to health care.
Kinya Ishikawa, MD, PhD Dr. Ishikawa has nothing to disclose.
Guy M. McKhann, MD No disclosure on file
Kathleen M. Shannon, MD, FAAN The institution of Dr. Shannon has received research support from Inhibikase Therapeutics. The institution of Dr. Shannon has received research support from ASKBIO. Dr. Shannon has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH.
Deborah Hall, MD, PhD, FAAN Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from NIH.
Susan Fox, MD, FAAN The institution of Dr. Fox has received research support from MJFF/Safra. The institution of Dr. Fox has received research support from Parkinson Canada. The institution of Dr. Fox has received research support from NIH. Dr. Fox has received publishing royalties from a publication relating to health care.
Michel Panisset, MD No disclosure on file
Teresa Pitts No disclosure on file
Andres M. Lozano, MD Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Functional Neuromodulation.
Christine M. Sapienza, PhD No disclosure on file
Michelle S. Troche, PhD No disclosure on file
Karen C. Albright, DO, DO, PhD, MS, MPH Dr. Albright has nothing to disclose.
Jody Corey-Bloom, MD, PhD, FAAN Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure. Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticaks. Dr. Corey-Bloom has received personal compensation in the range of $10,000-$49,999 for serving as a Co-Director, HD-Net with Huntington Study Group.
Jack J. Chen, PharmD BCPS CGP No disclosure on file
Antonio Strafella, MD No disclosure on file
Eva Pirogovsky No disclosure on file
Jean A. Jaglin, RN No disclosure on file
Masa-Aki Higuchi, MD No disclosure on file
Richard M. Dubinsky, MD, MPH, FAAN Dr. Dubinsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan Pharmaceuticals. An immediate family member of Dr. Dubinsky has stock in Abbvie and Abbott Labs. The institution of Dr. Dubinsky has received research support from CHDI. The institution of Dr. Dubinsky has received research support from Neurocrine. The institution of Dr. Dubinsky has received research support from Prilenia. The institution of Dr. Dubinsky has received research support from Sage Pharmaceuticals.
Susanne Grafe, MD No disclosure on file
Kelly D. Foote, MD Kelly D. Foote, MD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axio/Neurocrine Biosciences.
Chris E. Morrison, PhD No disclosure on file
Linda Winfield, RN No disclosure on file
Jeffrey Olech No disclosure on file
Jyh-Gong G. Hou, MD, PhD, FAAN No disclosure on file
William Bara-Jimenez, MD No disclosure on file
Yasuhiko Baba, MD, PhD No disclosure on file
Cynthia L. Comella, MD, FAAN Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Blair Ford, MD, FAAN No disclosure on file
Nozomu Sato, MD No disclosure on file
Luis D. Medina, PhD The institution of Dr. Medina has received research support from National Institutes of Health. Dr. Medina has received personal compensation in the range of $500-$4,999 for serving as a Speaker with AbbVie. Dr. Medina has a non-compensated relationship as a Council Member with Alzheimer's Association that is relevant to AAN interests or activities.
Monica E. Mazda, MD No disclosure on file
Joseph Jankovic, MD, FAAN Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Matthew A. Brodsky, MD Dr. Brodsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Brodsky has received research support from Boston Scientific.
Anne Marie Michon, NP No disclosure on file
Markos Poulopoulos, MD No disclosure on file
Connie C. Marras, MD Dr. Marras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. The institution of Dr. Marras has received research support from Theravance Inc. The institution of Dr. Marras has received research support from Centogene.
Melissa Armstrong, MD, MSc, FAAN, FAAN The institution of Dr. Armstrong has received research support from National Institute of Aging. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. Dr. Armstrong has received research support from Parkinson Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Genko Oyama, MD, PhD, FAAN Dr. Oyama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Oyama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Oyama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka Pharmaceutical Co. Ltd.. Dr. Oyama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sumitomo Dainippon Pharma Co. Ltd.. Dr. Oyama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai Co., Ltd.. Dr. Oyama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda Pharmaceutical Company LTD.. Dr. Oyama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Hakko Kirin Co. Ltd.. Dr. Oyama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie, Inc. The institution of Dr. Oyama has received research support from AbbVie, Inc. The institution of Dr. Oyama has received research support from GLORY LTD. The institution of Dr. Oyama has received research support from Kirin Company LTD. The institution of Dr. Oyama has received research support from Mitsubishi UFJ Lease & Finance Company LTD. The institution of Dr. Oyama has received research support from Sunwels Co., Ltd. The institution of Dr. Oyama has received research support from Ohara Pharmaceutical Co.,Ltd.. The institution of Dr. Oyama has received research support from PARKINSON Laboratories Co., Ltd..
Joseph Y. Matsumoto, MD Dr. Matsumoto has nothing to disclose.
Yasser M. Awaad, MD No disclosure on file
Paul Gilbert, PhD Dr. Gilbert has nothing to disclose.
Hamada H. Altalib, DO The institution of Dr. Altalib has received research support from UCB. The institution of Dr. Altalib has received research support from Eisai. The institution of Dr. Altalib has received research support from Sunovian. The institution of Dr. Altalib has received research support from DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS.
David Vaillancourt David Vaillancourt has received personal compensation for serving as an employee of Automated Imaging Diagnostics. David Vaillancourt has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of David Vaillancourt has received research support from NIH. David Vaillancourt has received intellectual property interests from a discovery or technology relating to health care.
Aliya Sarwar, MD Dr. Sarwar has received personal compensation in the range of $500-$4,999 for serving as a Amneal Fellowship Director Advisory Board Member with Amneal -Rytary.
M. M. Mouradian, MD, FAAN Dr. Mouradian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll Biopharma. Dr. Mouradian has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Society for Experimental Neurotherapeutics. Dr. Mouradian has stock in Alnylam, Eli Lilly. The institution of Dr. Mouradian has received research support from NIH, Michael J. Fox Foundation for Parkinson's Research; American Parkinson Disease Association. Dr. Mouradian has received intellectual property interests from a discovery or technology relating to health care. Dr. Mouradian has a non-compensated relationship as a Board of Directors with ANA that is relevant to AAN interests or activities.
Daniel Corcos, PhD Daniel Corcos, PhD has nothing to disclose.
Eugene C. Lai, MD, PhD, FAAN Dr. Lai has received publishing royalties from a publication relating to health care.
Elmyra V. Encarnacion, MD No disclosure on file
Jean A. Saint Cyr, PhD No disclosure on file
Frances M. Velez-Lago, MD No disclosure on file
Bryan T. Klassen, MD The institution of Dr. Klassen has received research support from Insightec.
Daniel D. Truong, MD, FAAN The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Truong has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Truong has received research support from Abbvie. The institution of Dr. Truong has received research support from Aeon. The institution of Dr. Truong has received research support from Biogen. The institution of Dr. Truong has received research support from Bukwang. The institution of Dr. Truong has received research support from Cerevel. The institution of Dr. Truong has received research support from Eli Lilly. The institution of Dr. Truong has received research support from Enterin. The institution of Dr. Truong has received research support from Ipsen. The institution of Dr. Truong has received research support from Lundbeck. The institution of Dr. Truong has received research support from Neurocrine. The institution of Dr. Truong has received research support from Neuroderm. The institution of Dr. Truong has received research support from Parkinson Foundation. The institution of Dr. Truong has received research support from Prilenia. The institution of Dr. Truong has received research support from Revance. The institution of Dr. Truong has received research support from Sunovion. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has a non-compensated relationship as a President with International Association for Parkinsonism and Related Disorders that is relevant to AAN interests or activities.
Gaela-Marie Mitchell No disclosure on file
Helen Shih No disclosure on file
Nicolás Phielipp, MD No disclosure on file
Alessandro Di Rocco, MD Dr. Di Rocco has nothing to disclose.
Scott E. Olson, MD No disclosure on file
Teodoro Bottiglieri, PhD No disclosure on file
Ryan J. Uitti, MD, FAAN Dr. Uitti has nothing to disclose.
Richard Brown No disclosure on file
Thomas N. Chase, MD Dr. Chase has received personal compensation for serving as an employee of Chase Therapeutics Corporation. Dr. Chase has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Riverside Pharmaceuticals Corporation. Dr. Chase has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Chase Therapeutics Corporation. Dr. Chase has received stock or an ownership interest from Chase Therapeutics Corporation. Dr. Chase has received stock or an ownership interest from Riverside Pharmaceuticals Corporation.
Anna Castrioto, MD No disclosure on file
Juha M. Savola, MD, PhD Dr. Savola has received personal compensation for serving as an employee of Teva Pharmaceuticals. Dr. Savola has received intellectual property interests from a discovery or technology relating to health care.
Virgilio Gerald H. Evidente, MD, FAAN Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Evidente has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Aeon. The institution of Dr. Evidente has received research support from Bukwang Pharmaceuticals. The institution of Dr. Evidente has received research support from Jazz Pharmaceuticals. The institution of Dr. Evidente has received research support from Scion Neurostim. The institution of Dr. Evidente has received research support from Theravance Biopharma. Dr. Evidente has received research support from Cerevance. Dr. Evidente has received research support from Ipsen.
Jonathan Howard, MD Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MCE Conferences. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has a non-compensated relationship as a Test writer with ABPN that is relevant to AAN interests or activities.
Jan Nolta, PhD No disclosure on file
Sergi Martinez-Ramirez, MD Dr. Martinez-Ramirez has nothing to disclose.
Vasiliki N. Ikonomidou No disclosure on file
Michael Marx, MD No disclosure on file
John Donahue No disclosure on file
Tyler E. Smith, MD Dr. Smith has received research support from National Multiple Sclerosis Society. Dr. Smith has received personal compensation in the range of $0-$499 for serving as a neurobytes author with 好色先生.
Alyssa Nylander, MD, PhD Dr. Nylander has nothing to disclose.
Damian Consalvo, MD No disclosure on file
Diego Ballesteros No disclosure on file
Farhaan S. Vahidy, MBBS, PhD Dr. Vahidy has nothing to disclose.
Laurie A. Schluter, RN, MSN, FNP No disclosure on file
Antreas Charidimou, MD, PhD MSc Dr. Charidimou has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care. Dr. Charidimou has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Journal of Neurological Sciences.
Duangnapa Roongpiboonsopit, MD No disclosure on file
Michael Korsmo, MD Dr. Korsmo has nothing to disclose.